Combination Targeted Therapy to Disrupt Aberrant Oncogenic...

  • Main
  • 2017 / 02
  • Combination Targeted Therapy to Disrupt Aberrant Oncogenic...

Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia

Shih, Alan H., Meydan, Cem, Shank, Kaitlyn, Garrett-Bakelman, Francine E., Ward, Patrick S., Intlekofer, Andrew M., Nazir, Abbas, Stein, Eytan M., Knapp, Kristina, Glass, Jacob, Travins, Jeremy, Stral
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-1049
Date:
February, 2017
File:
PDF, 5.17 MB
english, 2017
Conversion to is in progress
Conversion to is failed